InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: Mikenac post# 175466

Sunday, 02/10/2019 10:00:03 AM

Sunday, February 10, 2019 10:00:03 AM

Post# of 425942
Mikenac- Amarin is in need of a larger footprint. At this point Amarin isn't engaging in M&A, Amarin is executing their business plan, get Vascepa a strong and wide cardiovascular label based on the landmark R-I trial results. In the course of business Amarin is in the process of kicking ass in court. Here are active cases:

1) Patent fight with left-over generics after TEVA settled for 2029. Case is active in Nevada.
2) Amarin v. ITC (Really FDA). Case is waiting for a decision from Federal Court of Appeals.
3) Prosecuting 2 Supplement "fish oil" company's for falsely advertising using R-I landmark results. Case is active although is heavily leaning toward settlements in to separate California District Courts, Southern & Central.

IMO none of the above cases are even close to being resolved unfavorably regarding Amarin business.

Amarin doesn't NEED J&J or PFE or any other stupid BP that should have had the brains to engage in M&A in 2012.

BB

I do not pump Amarin stock. I am not an Amarin cheerleader. If I see something I don't like I make it known. Patients come first, always!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News